SSA
LAB icon

Schonfeld Strategic Advisors’s Standard BioTools LAB Stock Holding History

Schonfeld Strategic Advisors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$97.6K Buy
+118,639
New +$112K ﹤0.01% 2312
2024
Q3 		– Sell
-15,927
Closed -$28.2K – 2237
2024
Q2 		$28.2K Sell
15,927
-1,213,361
-99% -$2.97M ﹤0.01% 1984
2024
Q1 		$3.33M Buy
1,229,288
+1,038,004
+543% +$2.51M 0.02% 796
2023
Q4 		$423K Buy
191,284
+48,284
+34% +$103K ﹤0.01% 1341
2023
Q3 		$415K Buy
+143,000
New +$374K ﹤0.01% 1252
2022
Q3 		– Sell
-24,530
Closed -$39K – 3081
2022
Q2 		$39K Buy
+24,530
New +$60.7K ﹤0.01% 2256
2020
Q4 		– Sell
-210,600
Closed -$1.56M – 1728
2020
Q3 		$1.56M Buy
+210,600
New +$1.45M 0.03% 581
2020
Q2 		– Sell
-26,800
Closed -$68K – 1397
2020
Q1 		$68K Sell
26,800
-95,000
-78% -$312K ﹤0.01% 1035
2019
Q4 		$424K Sell
121,800
-213,400
-64% -$751K 0.01% 819
2019
Q3 		$1.55M Sell
335,200
-261,500
-44% -$2.06M 0.05% 372
2019
Q2 		$7.35M Sell
596,700
-555,900
-48% -$7.08M 0.26% 94
2019
Q1 		$15.3M Buy
1,152,600
+196,900
+21% +$2.08M 0.53% 32
2018
Q4 		$8.24M Buy
955,700
+530,300
+125% +$4.13M 0.32% 76
2018
Q3 		$3.19M Buy
425,400
+125,400
+42% +$891K 0.14% 203
2018
Q2 		$1.79M Buy
300,000
+150,494
+101% +$858K 0.1% 288
2018
Q1 		$873K Buy
+149,506
New +$982K 0.07% 356

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Schonfeld Strategic Advisors's LAB Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Standard BioTools (LAB) in Q2 2026: 118,639 shares worth $97.6K. The stake represents ﹤0.01% of the portfolio and ranks #2312 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in LAB as recently as Q2 2024.

Schonfeld Strategic Advisors first reported a position in LAB in Q1 2018 and has held it in 16 quarters since. The position peaked at $15.3M in Q1 2019. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Schonfeld Strategic Advisors held 118,639 shares of Standard BioTools worth $97.6K as of Q2 2026.
  • Standard BioTools was a new Schonfeld Strategic Advisors position in Q2 2026.
  • Standard BioTools made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #2312 holding.
  • Schonfeld Strategic Advisors first reported a position in Standard BioTools in Q1 2018 and has held it in 16 quarters since.
  • Schonfeld Strategic Advisors's Standard BioTools position peaked at $15.3M in Q1 2019.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.